107 related articles for article (PubMed ID: 16739319)
21. Intra-arterial ACNU and cisplatin chemotherapy for the treatment of glioblastoma multiforme.
Iwadate Y; Namba H; Sueyoshi K
Neurol Med Chir (Tokyo); 1995 Aug; 35(8):598-603. PubMed ID: 7566393
[TBL] [Abstract][Full Text] [Related]
22. Adjuvant intraarterial chemotherapy with nimustine in the management of World Health Organization Grade IV gliomas of the brain. Experience at the Department of Neurosurgery of Düsseldorf University.
Roosen N; Kiwit JC; Lins E; Schirmer M; Bock WJ
Cancer; 1989 Nov; 64(10):1984-94. PubMed ID: 2553234
[TBL] [Abstract][Full Text] [Related]
23. [Two cases of central nervous system leukemia which responded excellently to intra-arterial injection of ACNU].
Ohyasiki K; Ohsumi A; Ito H; Umehara S; Ohyashiki J; Yunokawa K; Osamura S; Tomita T; Ohta Y
Gan To Kagaku Ryoho; 1982 May; 9(5):942-7. PubMed ID: 6964042
[TBL] [Abstract][Full Text] [Related]
24. Phase I/II clinical trial of carbon ion radiotherapy for malignant gliomas: combined X-ray radiotherapy, chemotherapy, and carbon ion radiotherapy.
Mizoe JE; Tsujii H; Hasegawa A; Yanagi T; Takagi R; Kamada T; Tsuji H; Takakura K;
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):390-6. PubMed ID: 17459607
[TBL] [Abstract][Full Text] [Related]
25. Human interferon beta, nimustine hydrochloride, and radiation therapy in the treatment of newly diagnosed malignant astrocytomas.
Watanabe T; Katayama Y; Yoshino A; Fukaya C; Yamamoto T
J Neurooncol; 2005 Mar; 72(1):57-62. PubMed ID: 15803376
[TBL] [Abstract][Full Text] [Related]
26. Treatment of malignant gliomas: a new approach.
Paccapelo A; Piana C; Rychlicki F; Recchioni MA; Salvolini U; Ducati A; Bonsignori M
Tumori; 1998; 84(5):529-33. PubMed ID: 9862511
[TBL] [Abstract][Full Text] [Related]
27. Radiotherapy combined with nimustine hydrochloride and etoposide for malignant gliomas: results of a pilot study.
Tanaka M; Shibui S; Nomura K; Nakanishi Y
Jpn J Clin Oncol; 2001 Jun; 31(6):246-50. PubMed ID: 11463801
[TBL] [Abstract][Full Text] [Related]
28. Phase II evaluation of a 3-day infusion of topotecan in patients with recurrent ovarian or primary peritoneal cancer.
Herzog TJ; Powell MA; Rader JS; Gibb R; Mutch DG
Gynecol Oncol; 2006 Nov; 103(2):637-41. PubMed ID: 16781766
[TBL] [Abstract][Full Text] [Related]
29. Ventriculolumbar perfusion of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosou rea hydrochloride.
Kochi M; Kuratsu J; Mihara Y; Takaki S; Seto H; Uemura S; Ushio Y
Neurosurgery; 1993 Nov; 33(5):817-23. PubMed ID: 8264878
[TBL] [Abstract][Full Text] [Related]
30. A phase I clinical trial of the histone deacetylase inhibitor belinostat in patients with advanced hematological neoplasia.
Gimsing P; Hansen M; Knudsen LM; Knoblauch P; Christensen IJ; Ooi CE; Buhl-Jensen P
Eur J Haematol; 2008 Sep; 81(3):170-6. PubMed ID: 18510700
[TBL] [Abstract][Full Text] [Related]
31. [Intra-arterial chemotherapy with ACNU in the treatment of malignant gliomas].
Fujiwara T; Matsumoto Y; Tsuchida T; Honma Y; Mino S; Nagao S
Gan To Kagaku Ryoho; 1992 Apr; 19(4):489-95. PubMed ID: 1313668
[TBL] [Abstract][Full Text] [Related]
32. [The treatment of psoriasis. Critical study of the use of ACNU (nimustine hydrochloride)].
Imaizumi T; Mitsuhashi Y; Katabira Y
Ann Dermatol Venereol; 1986; 113(5):427-34. PubMed ID: 3472485
[TBL] [Abstract][Full Text] [Related]
33. Intra-arterial ACNU chemotherapy employing 20% mannitol osmotic blood-brain barrier disruption for malignant brain tumors.
Miyagami M; Tsubokawa T; Tazoe M; Kagawa Y
Neurol Med Chir (Tokyo); 1990 Aug; 30(8):582-90. PubMed ID: 1703636
[TBL] [Abstract][Full Text] [Related]
34. [Pharmacokinetics of ACNU in cerebrospinal fluid].
Imagawa K; Kawasaki M; Toda I; Hayashi M; Asai A; Nomura T
Gan To Kagaku Ryoho; 1982 Sep; 9(9):1543-8. PubMed ID: 6964049
[TBL] [Abstract][Full Text] [Related]
35. [Physiological effects and antitumor efficiency of ACNU in postoperative patients with stomach cancer--an evaluation of the treatment combined with FT-207 or 5-FU dry syrup].
Kaneko H; Sekizawa Y; Ohashi A; Inuo T; Tsuchiya S
Gan To Kagaku Ryoho; 1982 Mar; 9(3):496-502. PubMed ID: 6820900
[TBL] [Abstract][Full Text] [Related]
36. Phase I study of the novel epothilone analog ixabepilone (BMS-247550) in patients with advanced solid tumors and lymphomas.
Aghajanian C; Burris HA; Jones S; Spriggs DR; Cohen MB; Peck R; Sabbatini P; Hensley ML; Greco FA; Dupont J; O'Connor OA
J Clin Oncol; 2007 Mar; 25(9):1082-8. PubMed ID: 17261851
[TBL] [Abstract][Full Text] [Related]
37. A comparison of intraarterial carboplatin and ACNU for the treatment of gliomas.
Fujiwara T; Matsumoto Y; Honma Y; Kuyama H; Nagao S; Ohkawa M
Surg Neurol; 1995 Aug; 44(2):145-50. PubMed ID: 7502204
[TBL] [Abstract][Full Text] [Related]
38. Influence of modes of ACNU administration on tissue and blood drug concentration in malignant brain tumors.
Hori T; Muraoka K; Saito Y; Sasahara K; Inagaki H; Inoue Y; Adachi S; Anno Y
J Neurosurg; 1987 Mar; 66(3):372-8. PubMed ID: 3469331
[TBL] [Abstract][Full Text] [Related]
39. Effects of concurrent topotecan and radiation on 6-month progression-free survival in the primary treatment of glioblastoma multiforme.
Grabenbauer GG; Gerber KD; Ganslandt O; Richter A; Klautke G; Birkmann J; Meyer M
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):164-9. PubMed ID: 19695435
[TBL] [Abstract][Full Text] [Related]
40. Enhancement of ACNU treatment of the BT4An rat glioma by local brain hyperthermia and intra-arterial drug administration.
Schem BC; Krossnes BK
Eur J Cancer; 1995 Oct; 31A(11):1869-74. PubMed ID: 8541115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
